Invasive pneumococcal disease in a cohort of HIV-infected adults: Incidence and risk factors, 1990-2003

Research output: Contribution to journalArticle

Abstract

Objective: To investigate the association between the introduction of HAART and invasive pneumococcal disease (IPD) in HIV-infected patients. Methods: Incidence of IPD was determined from 1990 to 2003 in a cohort of HIV-infected individuals and a nested case-control study assessed risk factors of IPD. Results: There were 72 cases over 19 020 person-years of follow-up (overall IPD rate, 379/100 000 person-years). In the calendar periods 1990-1995, 1995-1998, and 1998-2003, the IPD incidence per 100 000 person-years was 279 [95% confidence interval (CI), 150-519], 377 (95% CI, 227-625) and 410 (95% CI, 308-545), respectively (P = 0.516). CD4 cell count < 200 cells/μl [odds ratio (OR), 3.0; 95% CI, 1.2-7.6), HIV RNA > 50 000 copies/ml (OR, 2.8; 95% CI, 1.2-6.5), hepatitis C (OR, 4.9; 95% CI, 1.7-14.9), serum albumin (OR, 0.1; 95% CI, 0.04-0.5), injection drug use in women (OR, 3.8; 95% CI, 1.6-8.8), and education beyond high school (OR, 0.2; 95% CI, 0.05-0.8) were significantly associated with IPD in multivariate analysis. No treatment factor, including HAART (OR, 0.7; 95% CI, 0.3-1.5) and pneumococcal vaccination (OR, 0.9; 95% CI, 0.5-1.6), was associated with IPD. Conclusions: IPD incidence did not change significantly during the widespread dissemination of HAART in this cohort. IPD risk was associated with several sociodemographic and clinical factors.

Original languageEnglish (US)
Pages (from-to)437-444
Number of pages8
JournalAIDS
Volume20
Issue number3
DOIs
StatePublished - Feb 1 2006

    Fingerprint

Keywords

  • HAART
  • HIV
  • Hepatitis C virus
  • Intravenous substance abuse
  • Invasive pneumococcal disease
  • Pneumococcal vaccines

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Infectious Diseases

Cite this